Shares of Zoetis ( ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...

Bio-Serv's MD's™ (Medicated Dosing System) and Medicated Feeds product lines offer safe, accurate, and labor-saving alternatives to traditional methods of administering oral or injectable ...

The medicated feed market drives animal health and productivity through innovative, regulated, and efficient solutions ensuring safe and sustainable livestock nutrition.” - Exactitude ...

Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...

Zoetis stock plunged Thursday after the company's 2025 guidance missed forecasts, though fourth-quarter metrics beat.

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2024 as well as provided ...

Zoetis posted Q4 earnings above estimates with strong organic growth. 2025 guidance signals lower-than-expected revenue and EPS, sending shares down.

Bobwhite quail in the Rolling Plains of Texas Texas Tech University Wildlife Toxicology Lab article lays out QuailGuard®'s success story fo ...

ZTS delivered fourth-quarter 2024 adjusted earnings (excluding one-time items) of $1.40 per share, which surpassed the Zacks ...